Revisited analysis of a SHIVA01 trial cohort using functional mutational analyses successfully predicted treatment outcome.

Saved in:
Bibliographic Details
Title: Revisited analysis of a SHIVA01 trial cohort using functional mutational analyses successfully predicted treatment outcome.
Authors: Kamal M; Department of Drug Development and Innovation, Institut Curie, Paris & Saint-Cloud, France., Tarcic G; NovellusDx, Jerusalem, Israel., Dureau S; Department of Biostatistics, Institut Curie, Paris, France., Edelheit O; NovellusDx, Jerusalem, Israel., Barbash Z; NovellusDx, Jerusalem, Israel., Lecerf C; Department of Drug Development and Innovation, Institut Curie, Paris & Saint-Cloud, France., Morel C; Department of Drug Development and Innovation, Institut Curie, Paris & Saint-Cloud, France., Miron B; NovellusDx, Jerusalem, Israel., Callens C; Department of genetics, Institut Curie, Paris, France., Servant N; Institut Curie/INSERM U900, Saint-Cloud, France., Bieche I; Department of genetics, Institut Curie, Paris, France., Vidne M; NovellusDx, Jerusalem, Israel., Le Tourneau C; Department of Drug Development and Innovation, Institut Curie, Paris & Saint-Cloud, France.; Institut Curie/INSERM U900, Saint-Cloud, France.; Versailles-Saint-Quentin-en-Yvelines University, Montigny-le-Bretonneux, France.
Source: Molecular oncology [Mol Oncol] 2018 May; Vol. 12 (5), pp. 594-601. Date of Electronic Publication: 2018 Mar 30.
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1878-0261
DOI:10.1002/1878-0261.12180